You just need to fill in the form to make sure you qualify. Once the Obvio-19 app goes live, you will receive an email with instructions on how to download it. From there, you will be asked to complete a number of brief surveys over the course of several months and may also be asked to take a finger-prick test (when they become available in the US) to determine whether you have been exposed to COVID-19 (based on your immune system’s response to the virus). The personal information you provide will be accessible only by a small number team of study staff, but all identifiable information will be removed before the study data is made publicly available for researchers around the world.
With just a bit of your time and attention, you can be a part of the solution to a global pandemic by providing essential information through symptom tracking and responses to health-related questions. Your contributions may help shape response strategies around the world, as well as add to important data sources for public policy moving forward.
Yes! When you complete the form, you will be assigned a Participant ID. With the exception of the Study Doctor and Study Coordinator, anyone accessing the data on the individual level will only be able to see your Participant ID with no Personally Identifiable Information (email, name, phone) available.
Everyone! As long as you are over 18, plan to be in the United States for at least the next 6 months and have regular access to a smartphone and reliable internet, you are eligible to join.
Fill out a brief questionnaire.
Once submitted, we will immediately let you know whether you are eligible and provide instructions for next steps.
Click here to learn more about the Obvio-19 study on clinicaltrials.gov.
Please note: ObvioHealth may store your data in a confidential and secure database. Personal information will never be shared with or sold to any other persons or organizations not associated with ObvioHealth. ObvioHealth may/will use personal information to contact you directly by phone and/or email for matters related to potential participation in clinical trials for which the potential subject may qualify.
For more information about COVID-19, including how to protect yourself and what to do if you're sick, visit the CDC website.